Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-10

Clinical Trial Update: This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD) [NA]

View source ↗

Summary

This LMU project will evaluate whether an AI second-opinion report used to analyze retinal scans influences doctors' treatment decisions for neovascular Age-Rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johannes Schiefelbein | Conditions: Neovascular Age-Related Macular Degeneration (nAMD) | NA | Status: NOT_YET_RECRUITING